Intrinsiqq
Gyre Therapeutics Inc. logo

Gyre Therapeutics Inc. Insider Trading

GYRE

⊜ Compare
Last 12 months

Insiders sold 953K and bought nothing on the open market.

9% of the selling was scheduled in advance under 10b5-1 plans. The last open-market buy by an executive or director was in Aug 2022.

Net open-market
−953K
0 buys · 9 sales
Under a 10b5-1 plan
9%
of the value sold
Insiders who bought / sold
0 / 2
executives and directors
Last open-market buy
Aug 2022
Aug 9, 2022

Get an email when GYRE's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Jun 9 – 18No plan
    Weiguo Ye
    Chief Operating Officer · sold 11,000 at avg $6.25
    69K
    1.5% of stake
  • Jun 11No plan
    Weiguo Ye
    Chief Operating Officer · sold 2,800 at $6.17
    17K
    0.4% of stake
  • Jun 9 – 10No plan
    Weiguo Ye
    Chief Operating Officer · sold 20,918 at avg $6.16
    129K
    2.9% of stake
  • Jun 4 – 5No plan
    Weiguo Ye
    Chief Operating Officer · sold 34,976 at avg $6.25
    219K
    4.8% of stake
  • May 22 – 26No plan
    Weiguo Ye
    Chief Operating Officer · sold 7,500 at avg $6.09
    46K
    1.1% of stake
  • May 20 – 21No plan
    Weiguo Ye
    Chief Operating Officer · sold 22,220 at avg $6.15
    137K
    3.1% of stake
  • May 18 – 19No plan
    Weiguo Ye
    Chief Operating Officer · sold 9,320 at avg $6.38
    59K
    1.3% of stake
  • May 14 – 15No plan
    Weiguo Ye
    Chief Operating Officer · sold 28,680 at avg $6.79
    195K
    3.9% of stake
  • May 5 – 610b5-1 plan
    Ying Luo
    Chief Executive Officer · sold 10,315 at avg $8.04
    83K
    0.4% of stake
  • May 27, 2025 – May 28, 202510b5-1 plan
    Songjiang Ma
    President · sold 2,558 at avg $10.23
    26K
    <0.1% of stake
  • May 22, 2025 – May 23, 202510b5-1 plan
    Songjiang Ma
    President · sold 2,182 at avg $10.91
    24K
    <0.1% of stake
  • May 20, 2025 – May 21, 202510b5-1 plan
    Songjiang Ma
    President · sold 4,000 at avg $11.04
    44K
    0.1% of stake
  • May 16, 2025 – May 19, 202510b5-1 plan
    Songjiang Ma
    President · sold 4,000 at avg $11.21
    45K
    0.1% of stake
  • May 14, 2025 – May 15, 202510b5-1 plan
    Songjiang Ma
    President · sold 2,020 at avg $10.69
    22K
    <0.1% of stake
  • May 12, 2025 – May 13, 202510b5-1 plan
    Songjiang Ma
    President · sold 4,000 at avg $10.97
    44K
    0.1% of stake
  • Mar 21, 202510b5-1 plan
    Songjiang Ma
    President · sold 174 at $10.00
    2K
    <0.1% of stake
  • Mar 19, 2025 – Mar 20, 202510b5-1 plan
    Songjiang Ma
    President · sold 4,000 at avg $10.11
    40K
    0.1% of stake
  • Mar 17, 2025 – Mar 18, 202510b5-1 plan
    Songjiang Ma
    President · sold 2,242 at avg $11.89
    27K
    <0.1% of stake
  • Mar 13, 2025 – Mar 14, 202510b5-1 plan
    Songjiang Ma
    President · sold 4,000 at avg $12.06
    48K
    0.1% of stake
  • Mar 11, 2025 – Mar 12, 202510b5-1 plan
    Songjiang Ma
    President · sold 4,000 at avg $11.57
    46K
    0.1% of stake
  • Mar 7, 2025 – Mar 10, 202510b5-1 plan
    Songjiang Ma
    President · sold 4,000 at avg $10.19
    41K
    0.1% of stake
  • Mar 5, 2025 – Mar 6, 202510b5-1 plan
    Songjiang Ma
    President · sold 4,000 at avg $10.89
    44K
    0.1% of stake
  • Mar 3, 2025 – Mar 4, 202510b5-1 plan
    Songjiang Ma
    President · sold 4,000 at avg $11.05
    44K
    0.1% of stake
  • Feb 27, 2025 – Feb 28, 202510b5-1 plan
    Songjiang Ma
    President · sold 4,000 at avg $11.37
    45K
    0.1% of stake
  • Feb 25, 2025 – Feb 26, 202510b5-1 plan
    Songjiang Ma
    President · sold 4,000 at avg $11.50
    46K
    0.1% of stake
  • Feb 21, 2025 – Feb 24, 202510b5-1 plan
    Songjiang Ma
    President · sold 4,000 at avg $11.30
    45K
    0.1% of stake
  • Feb 19, 2025 – Feb 20, 202510b5-1 plan
    Songjiang Ma
    President · sold 4,000 at avg $12.35
    49K
    0.1% of stake
  • Feb 14, 2025 – Feb 18, 202510b5-1 plan
    Songjiang Ma
    President · sold 4,000 at avg $12.22
    49K
    0.1% of stake
  • Feb 12, 2025 – Feb 13, 202510b5-1 plan
    Songjiang Ma
    President · sold 4,000 at avg $11.59
    46K
    0.1% of stake
  • Feb 10, 2025 – Feb 11, 202510b5-1 plan
    Songjiang Ma
    President · sold 3,878 at avg $11.72
    45K
    0.1% of stake
  • Feb 6, 2025 – Feb 7, 202510b5-1 plan
    Songjiang Ma
    President · sold 4,000 at avg $12.51
    50K
    0.1% of stake
  • Feb 4, 2025 – Feb 5, 202510b5-1 plan
    Songjiang Ma
    President · sold 4,000 at avg $12.01
    48K
    0.1% of stake
  • Jan 31, 2025 – Feb 3, 202510b5-1 plan
    Songjiang Ma
    President · sold 4,000 at avg $11.49
    46K
    0.1% of stake
  • Jan 29, 2025 – Jan 30, 202510b5-1 plan
    Songjiang Ma
    President · sold 4,000 at avg $11.40
    46K
    0.1% of stake
  • Jan 27, 2025 – Jan 28, 202510b5-1 plan
    Songjiang Ma
    President · sold 4,000 at avg $11.35
    45K
    0.1% of stake
  • Jan 23, 2025 – Jan 24, 202510b5-1 plan
    Songjiang Ma
    President · sold 4,000 at avg $10.69
    43K
    0.1% of stake
  • Jan 21, 2025 – Jan 22, 202510b5-1 plan
    Songjiang Ma
    President · sold 4,000 at avg $10.74
    43K
    0.1% of stake
  • Jan 16, 2025 – Jan 17, 202510b5-1 plan
    Songjiang Ma
    President · sold 4,000 at avg $10.72
    43K
    0.1% of stake
  • Jan 14, 2025 – Jan 15, 202510b5-1 plan
    Songjiang Ma
    President · sold 4,000 at avg $10.62
    42K
    0.1% of stake
  • Jan 10, 2025 – Jan 13, 202510b5-1 plan
    Songjiang Ma
    President · sold 1,113 at avg $10.02
    11K
    <0.1% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch GYRE, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with GYRE

CompareIntrinsic value
SPRYArs Pharmaceuticals Inc
$3.05+0.00%40
RCUSArcus Biosciences Inc.
$19.31+2.12%10
ETONEton Pharmaceuticals Inc.
$50.72-0.45%75
XNCRXencor Inc.
$35.01+14.28%0
TBPHTheravance Biopharma Inc.
No recent price82
ASRTAssertio Holdings Inc.
$9.09+0.28%10
SEPNSepterna, Inc.
$47.88+9.57%46
AGIOAgios Pharmaceuticals Inc.
$31.38+0.58%40

Held by ETFs

GYRE is in 3 US ETFs. The largest of them, with GYRE's weight in each:

Spot a number that looks wrong? Check it in GYRE's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing GYRE

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.